In vitro hematopoietic differentiation of mouse embryonic stem cells requires the tumor suppressor menin and is mediated by Hoxa9

Mechanisms of Development

Volumn 126, Issue 7, 2009, Pages 517-522

  Novotny, Elizabeth ^a   Compton, Sheila ^a   Liu, P Paul ^a   Collins, Francis S ^a   Chandrasekharappa, Settara C ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Embryonic stem cells; ES; Hematopoiesis; Hoxa9; Menin; Mixed lineage leukemia; Multiple endocrine neoplasia type 1

Indexed keywords

HOMEODOMAIN PROTEIN; METHIONINE; PROTEIN HOXA9; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIESIS; HOMEODOMAIN PROTEINS; HUMANS; MICE; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 67349212161     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mod.2009.04.001     Document Type: Article

References (19)

1. Ayton P.M., and Cleary M.L. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 17 (2003) 2298-2307
2. Caslini C., Yang Z., El-Osta M., Milne T.A., Slany R.K., and Hess J.L. Interaction of MLL amino terminal sequences with menin is required for transformation. Cancer Res. 67 (2007) 7275-7283
3. Castilla L.H., Wijmenga C., Wang Q., Stacy T., Speck N.A., Eckhaus M., Marin-Padilla M., Collins F.S., Wynshaw-Boris A., and Liu P.P. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87 (1996) 687-696
4. Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.E., Collins F.S., Emmert-Buck M.R., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weisemann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim Y.S., Heppner C., Dong Q., Spiegel A.M., Burns A.L., and Marx S.J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 (1997) 404-407
5. Chandrasekharappa S.C., and Teh B.T. Functional studies of the MEN1 gene. J. Intern. Med. 253 (2003) 606-615
6. Chen Y.X., Yan J., Keeshan K., Tubbs A.T., Wang H., Silva A., Brown E.J., Hess J.L., Pear W.S., and Hua X. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc. Natl. Acad. Sci. USA 103 (2006) 1018-1023
7. Crabtree J.S., Scacheri P.C., Ward J.M., Garrett-Beal L., Emmert-Buck M.R., Edgemon K.A., Lorang D., Libutti S.K., Chandrasekharappa S.C., Marx S.J., Spiegel A.M., and Collins F.S. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc. Natl. Acad. Sci. USA 98 (2001) 1118-1123
8. Ernst P., Fisher J.K., Avery W., Wade S., Foy D., and Korsmeyer S.J. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev. Cell 6 (2004) 437-443
9. Ernst P., Mabon M., Davidson A.J., Zon L.I., and Korsmeyer S.J. An Mll-dependent Hox program drives hematopoietic progenitor expansion. Curr. Biol. 14 (2004) 2063-2069
10. Guru S.C., Goldsmith P.K., Burns A.L., Marx S.J., Spiegel A.M., Collins F.S., and Chandrasekharappa S.C. Menin, the product of the MEN1 gene, is a nuclear protein. Proc. Natl. Acad. Sci. USA 95 (1998) 1630-1634
11. Hess J.L., Bittner C.B., Zeisig D.T., Bach C., Fuchs U., Borkhardt A., Frampton J., and Slany R.K. C-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood 108 (2006) 297-304
12. Hughes C.M., Rozenblatt-Rosen O., Milne T.A., Copeland T.D., Levine S.S., Lee J.C., Hayes D.N., Shanmugam K.S., Bhattacharjee A., Biondi C.A., Kay G.F., Hayward N.K., Hess J.L., and Meyerson M. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell 13 (2004) 587-597
13. Kabrun N., Buhring H.J., Choi K., Ullrich A., Risau W., and Keller G. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124 (1997) 2039-2048
14. Maillard I., Chen Y.X., Friedman A., Yang Y., Tubbs A.T., Shestova O., Pear W.S., and Hua X. Menin regulates the function of hematopoietic stem cells and lymphoid progenitors. Blood 113 (2009) 1661-1669
15. Marx S.J. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat. Rev. Cancer 5 (2005) 367-375
16. Popovic R., Erfurth F., and Zeleznik-Le N. Transcriptional complexity of the HOXA9 locus. Blood Cells Mol. Dis. 40 (2008) 156-159
17. Whelan J.T., Ludwig D.L., and Bertrand F.E. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia. Leukemia 22 (2008) 1161-1169
18. Yokoyama A., Somervaille T.C., Smith K.S., Rozenblatt-Rosen O., Meyerson M., and Cleary M.L. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 (2005) 207-218
19. Yokoyama A., Wang Z., Wysocka J., Sanyal M., Aufiero D.J., Kitabayashi I., Herr W., and Cleary M.L. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24 (2004) 5639-5649